TRPV4
TRPV4 (transient receptor potential cation channel subfamily V member 4) is a Ca2+-permeable, nonselective cation channel of the TRP superfamily. It is also known as OTRPC4, TRP12, VROAC, VRL-2, VR-OAC and CMT2C, and is thought to help regulate systemic osmotic pressure. Browse Assay Genie's current range of TRPV4 research reagents below, or read on for the biology behind the target.
TRPV4 is a Ca2+-permeable, nonselective cation channel that belongs to the OSM9-like transient receptor potential channel (OTRPC) subfamily within the transient receptor potential (TRP) superfamily of ion channels. It is thought to be involved in the regulation of systemic osmotic pressure. In the UniProt classification it sits in the TrpV subfamily, in the TRPV4 sub-subfamily of the transient receptor family (TC 1.A.4).
The TRPV4 protein is annotated at several cellular sites: the cell membrane, including the apical cell membrane, adherens junctions, the cilium and the endoplasmic reticulum. HGNC places the TRPV4 gene in two groups, the ankyrin repeat domain containing proteins and the transient receptor potential cation channel subfamily V. Multiple transcript variants encoding different isoforms have been reported for the gene. Orthologues are present in mouse and rat, both named Trpv4.
Mutations in the TRPV4 gene cause spondylometaphyseal dysplasia, metatropic dysplasia and hereditary motor and sensory neuropathy type IIC, which accounts for the CMT2C alias. UniProt also records a role in microbial infection: TRPV4 facilitates Zika virus replication, possibly through its action on DDX3X. The earlier HGNC name was transient receptor potential cation channel, subfamily V, member 4, and the symbols OTRPC4, TRP12, VRL-2 and VR-OAC are still found in the literature.
TRPV4 is thought to be involved in the regulation of systemic osmotic pressure, making it a focus for work on osmosensing and cation flux.
Mutations in TRPV4 cause spondylometaphyseal dysplasia and metatropic dysplasia, so the channel is studied in the biology of skeletal development disorders.
TRPV4 mutations cause hereditary motor and sensory neuropathy type IIC, linking the channel to inherited peripheral nerve disease.
TRPV4 facilitates Zika virus replication, possibly through DDX3X, which makes it relevant to studies of host factors in flavivirus infection.
TRPV4 is a Ca2+-permeable, nonselective cation channel thought to be involved in regulating systemic osmotic pressure. UniProt also notes that it facilitates Zika virus replication, possibly through its action on DDX3X. It is found at the cell membrane, cilia, adherens junctions and the endoplasmic reticulum.
TRPV4 is also called OTRPC4, TRP12, VROAC, VRL-2, VR-OAC and CMT2C. The older HGNC name was transient receptor potential cation channel, subfamily V, member 4. Multiple transcript variants of the gene encode different isoforms, so check the datasheet of any product for its validated reactivity.
Yes. Mutations in the TRPV4 gene cause spondylometaphyseal dysplasia, metatropic dysplasia and hereditary motor and sensory neuropathy type IIC. Mouse and rat both carry a Trpv4 orthologue, which allows the channel to be studied in rodent models.
Other members of the TRPV subfamily of TRP cation channels with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9HBA0; product specifications from Assay Genie datasheets.